Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $13.11 $15.83 Friday, 10th May 2024 SRRK stock ended at $13.35. This is 8.25% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 8.97% from a day low at $13.19 to a day high of $14.37.
90 days $12.81 $17.90
52 weeks $5.56 $21.17

Historical Scholar Rock Holding Corp. prices

Date Open High Low Close Volume
Oct 05, 2023 $6.72 $7.32 $6.61 $7.28 253 592
Oct 04, 2023 $6.66 $6.80 $6.55 $6.77 228 115
Oct 03, 2023 $6.44 $6.68 $6.23 $6.65 245 924
Oct 02, 2023 $7.05 $7.10 $6.34 $6.52 318 055
Sep 29, 2023 $7.21 $7.34 $7.06 $7.10 309 021
Sep 28, 2023 $7.11 $7.34 $6.95 $7.29 242 466
Sep 27, 2023 $6.76 $7.21 $6.76 $7.11 324 271
Sep 26, 2023 $6.45 $6.92 $6.45 $6.79 481 451
Sep 25, 2023 $6.33 $6.50 $6.24 $6.44 247 461
Sep 22, 2023 $6.32 $6.39 $6.03 $6.36 254 253
Sep 21, 2023 $6.86 $6.86 $6.22 $6.31 309 672
Sep 20, 2023 $7.00 $7.39 $6.90 $6.96 356 426
Sep 19, 2023 $6.25 $7.12 $6.13 $6.91 401 416
Sep 18, 2023 $6.34 $6.37 $5.94 $6.24 245 487
Sep 15, 2023 $6.25 $6.49 $6.20 $6.40 1 611 959
Sep 14, 2023 $6.09 $6.31 $6.02 $6.24 184 242
Sep 13, 2023 $6.21 $6.32 $6.06 $6.09 175 584
Sep 12, 2023 $6.09 $6.38 $6.09 $6.20 134 248
Sep 11, 2023 $6.20 $6.26 $6.09 $6.16 121 517
Sep 08, 2023 $6.27 $6.31 $6.09 $6.15 176 443
Sep 07, 2023 $6.20 $6.31 $6.12 $6.26 169 231
Sep 06, 2023 $6.04 $6.24 $5.97 $6.23 219 121
Sep 05, 2023 $6.26 $6.27 $5.98 $6.04 557 021
Sep 01, 2023 $6.26 $6.53 $6.26 $6.29 168 353
Aug 31, 2023 $6.03 $6.39 $6.03 $6.25 300 389
Click to get the best stock tips daily for free!

About Scholar Rock Holding Corp.

Scholar Rock Holding . Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical tria... SRRK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT